SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001562180-24-001343
Filing Date
2024-02-15
Accepted
2024-02-15 18:02:50
Documents
2
Period of Report
2024-02-07

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primarydocument.html 3  
1 PRIMARY DOCUMENT primarydocument.xml 3 1816
2 POA_BURROUGHS poa_burroughs.txt EX-24 5364
  Complete submission text file 0001562180-24-001343.txt   8639
Mailing Address 1065 EAST HILLSDALE BLVD., SUITE 100 FOSTER CITY CA 94404
Business Address 1065 EAST HILLSDALE BLVD., SUITE 100 FOSTER CITY CA 94404 650-525-5535 EXT.101
Terns Pharmaceuticals, Inc. (Issuer) CIK: 0001831363 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address TWO CARLSON PARKWAY, SUITE 260 MINNEAPOLIS MN 55447
Business Address
Burroughs Amy L. (Reporting) CIK: 0001872564 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39926 | Film No.: 24645154